CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | BOHLIN GAREN G Director | Grant or award | +9,941 | 20,948 | ||
| 2021-05-10 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −7,000 | $22.77 | $159K | 89,990 |
| 2021-04-01 | Malamut Richard EVP and Chief Medical Officer | Shares withheld for taxes | −3,119 | $23.38 | $73K | 93,558 |
| 2021-04-01 | Fleming Alison B EVP & Chief Technical Officer | Shares withheld for taxes | −1,757 | $23.38 | $41K | 152,980 |
| 2021-04-01 | Fleming Alison B EVP & Chief Technical Officer | Shares withheld for taxes | −7,900 | $23.38 | $185K | 145,080 |
| 2021-03-30 | Fleming Alison B Chief Technical Officer | Grant or award | +5,984 | 154,737 | ||
| 2021-03-16 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −734 | $24.69 | $18K | 96,990 |
| 2021-03-15 | Heffernan Michael Thomas Director | Sale | −47,044 | $25.26 | $1.2M | 7,078 |
| 2021-03-15 | Heffernan Michael Thomas Director | Sale | −3,031 | $25.88 | $78K | 4,047 |
| 2021-03-01 | Ciaffoni Joseph President and CEO | Option exercise | +48,616 | $8.22 | $400K | 343,075 |
| 2021-03-01 | Ciaffoni Joseph President and CEO | Sale | −54,959 | $22.56 | $1.2M | 288,116 |
| 2021-03-01 | Ciaffoni Joseph President and CEO | Sale | −9,809 | $23.30 | $229K | 278,307 |
| 2021-03-01 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −48,616 | 16,205 | ||
| 2021-03-01 | Fleming Alison B Chief Technical Officer | Sale | −6,011 | $23.36 | $140K | 148,753 |
| 2021-02-11 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −2,100 | $24.89 | $52K | 89,056 |
| 2021-02-11 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −5,798 | $25.33 | $147K | 83,258 |
| 2021-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −1,901 | $25.95 | $49K | 94,439 |
| 2021-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −3,283 | $25.95 | $85K | 91,156 |
| 2021-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −2,163 | $25.95 | $56K | 101,419 |
| 2021-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −3,695 | $25.95 | $96K | 97,724 |
Page 18 of 24 · 462 trades